So, while improving our understanding of underlying sex dimorphism in AD risk will be critical for developing treatments that are especially effective in women, this line of research also has the potential to reveal new targets for the treatment of AD and other neurodegenerative disorders in both sexes.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}